-+ 0.00%
-+ 0.00%
-+ 0.00%

Keros Therapeutics director Jean Jacques Bieneaime acquires USD 10,270 in common shares

PUBT·08/19/2026 20:10:53
Listen to the news
Keros Therapeutics director Jean Jacques Bieneaime acquires USD 10,270 in common shares
  • Keros Therapeutics director Jean Jacques Bienaime bought 1,000 common shares at a weighted average USD 10.27.
  • Directly held stake rose to 19,592 shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Keros Therapeutics Inc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001221590-26-000025), on August 19, 2026, and is solely responsible for the information contained therein.